Ecologia do vírus SARS-CoV-2 e estado atual da COVID-19/ SARS-CoV-2 virus ecology and current state of COVID-19

Authors

  • Fernando Portela Câmara
  • Marcelo Moreno

DOI:

https://doi.org/10.34119/bjhrv4n3-263

Keywords:

COVID-19, sarbecovírus, SARS-CoV-2.

Abstract

Embora o SARS-CoV-2 tenha sido colocado no subgênero Sarbecovirus, seu protótipo genético não foi isolado ainda de morcegos, além do fato de ele não ser relevantemente infeccioso para esses animais. Ele também possui uma inserção de 12 nucleotídeos não encontrada em outros coronavírus e que que o torna muito infeccioso para humanos. Da mesma forma, não foi ainda identificado o possível hospedeiro intermediário que supostamente tenha sido o elo que deu início a atual pandemia a partir de Wuhan. Em síntese, nada sabemos sobre como surgiu a Covid-19. A OMS denominou a doença que ora fustiga o planeta de COVID-19, uma designação inadequada e que nada informa. Trata-se, porém de uma forma altamente infecciosa da SARS, e por isso deveria ser denominada de SARS-2, conforme os virologistas reconheceram ao classificar o vírus causador

References

Câmara FP, Câmara DCP, Moreno M. Seguranc?a em laborato?rios de microbiologia e risco de epidemias. Brazilian Journal of Health Review, 2020a; 3:13396-13402, DOI:10.34119/bjhrv3n5-164.

Câmara FP, Câmara DCP, Moreno M. Covid-19: trajeto?ria atual e futura. Brazilian Journal of Health Review, Curitiba, 2020b; 3:13377-13382, DOI:10.34119/bjhrv3n5-162.

Câmara FP, Câmara DCP, Moreno M. Conta?gio e virule?ncia: covid-19 e a pro?xima pandemia. Brazilian Journal of Health Review, Curitiba, 2020c; 3: 13353-13357, DOI:10.34119/bjhrv3n5-160.

CDC.GOV. SARS-CoV-2 Variant Classifications and Definitions. Acessohttps://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html Acesso 05/06/2021.

Channappanavar R, Fehr AR, Vijay R, Mack M, Zhao J, Meyerholz DK, Perlman S. Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice, Cell Host & Microbe 2016;19: 181-193, DOI: 10.1016/j.chom.2016.01.007.

Coronaviridae Study Group of the International Committee on Taxonomy of Viruses (ICTV). The species Severe acute respiratory syndrome related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology. VOL 5, March 202, 536–544. 2020. https://doi.org/10.1038/s41564-020-0695-z.

COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU).

https://gisanddata.maps.arcgis.com/apps/dashboards/bda7594740fd40299423467b48e9ecf6. Acesso 06/05/2020.

Coutard B, Valle C, de Lamballerie X et al. The spike glycoprotein of the new coronavirus 2019- nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res 2020; 176:104742. D.O.I. 10.1016/j. antiviral.2020.104742

Drexler JF, Corman VM, Drosten C . Ecology, evo-lution and classification of bat coronaviruses in the aftermathof SARS, Antiviral Research, 2014; 101: 45–56

Henderson LA, Canna SW, Schulert GS, et al. On the alert for cytokine storm: immunopathology in COVID-19. Arthritis Rheumatol 2020; 72: 1059–63.

Huang YW et al. Origin, evolution, and genotyping of emergent porcine epidemic diarrhea virus strains in the United States. mBio, 4: e00737–13. 2013. DOI: https://doi.org/10.1038/s41586-018-0010-9.

ICTV (International Committee on Taxonomy of Viruses). Naming the 2019 Coronavirus. https://talk.ictvonline.org/information/w/news/1300/page. Acesso 06/06/2021.

Liu J, Xie W, Wang Y et al. A comparative overview of COVID-19, MERS and SARS: Review article. International Journal of Surgery 81 (2020) 1–8. https://doi.org/10.1016/j.ijsu.2020.07.032

Melo CML, Silva GAS, Melo ARS, Freitas AC. COVID-19 pandemic outbreak: the Brazilian reality from the first case to the collapse of health services. An Acad Bras Cienc 2020; 92: e20200709, DOI 10.1590/0001-3765202020200709 .

Moreno M, Coelho MLRA, Câmara FP. COVID-19 em atletas no campeonato brasileiro de futebol (Brasileirão) de 2020, Brazilian Journal of Development, 2021; 7: 35867-35874, DOI:10.34117/bjdv7n4-175.

Segreto S, Deigin Y, McCairn K et al. Should we discount the laboratory origin of COVID 19? Environmental Chemistry Letters (jun 2021), pub online D.O.I. 10.1007/s10311-021-01211-0

Shang J, Wan Y, Luo C, et al. Cell entry mechanisms of SARS-CoV-2, PNAS 2020; 117: 11727–11734.

Tang T, Jaimes JA, Bidon MK et al. Proteolytic activation of SARS-CoV-2 spike at the S1/ S2 boundary: potential role of proteases beyond furin. ACS Infect Dis 2021; 7:264–272. D.O.I. 10.1021/acsinfecdis. 0c00701.

Wacharapluesadee S, Tan CW, Maneeorn P et al. Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia. Nature Communications 2021; 12:972, D.O.I. 10.1038/s41467-021-21240-1

Wang C, Horby PW, Hayden FG, Gao GT. A novel coronavirus outbreak of global health concern. The Lancet Volume 395 Issue 10223 Pages 470-473 (February 2020), DOI: 10.1016/S0140-6736(20)30185-9

WHO, Situation Report -22, 11 February 2020. Novel Coronavirus (2019-nCoV). https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200211-sitrep-22-ncov.pdf?sfvrsn=fb6d49b1_2. Acesso 06/06/2021.

Wit, E, Doremalen, NV, Falzarano D, Munster VJ. SARS and MERS: Recent insights into emerging coronaviruses, Nature Reviews of Microbiology 2016; 14: 523-534.

Wu C, Zheng M, Yang Y et al. Furin: a potential therapeutic target for COVID-19. Science 2020; 23:101642. D.O.I. 10.1016/j. isci.2020.101642

Zhan SH, Deverman BE, Chan YA. SARS-CoV-2 is well adapted for humans. What does this mean for re-emergence? bioRxiv, May 1, 2020, D.O.I. 10.1101/2020.05.01.073262

Published

06/15/2021

How to Cite

CÂMARA, F. P.; MORENO, M. Ecologia do vírus SARS-CoV-2 e estado atual da COVID-19/ SARS-CoV-2 virus ecology and current state of COVID-19. Brazilian Journal of Health Review, [S. l.], v. 4, n. 3, p. 13106–13112, 2021. DOI: 10.34119/bjhrv4n3-263. Disponível em: https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/31303. Acesso em: 20 oct. 2026.

Issue

Section

Original Papers